title: Rapamycin regulates the phosphorylation of rictor.
abstract: The mammalian target of rapamycin (mTOR) is a central regulator of cell growth. mTOR exists in two functional complexes, mTORC1 and mTORC2. mTORC1 is rapamycin-sensitive, and results in phosphorylation of 4E-BP1 and S6K1. mTORC2 is proposed to regulate Akt Ser473 phosphorylation and be rapamycin-insensitive. mTORC2 consists of mTOR, mLST8, sin1, Protor/PRR5, and the rapamycin insensitive companion of mTOR (rictor). Here, we show that rapamycin regulates the phosphorylation of rictor. Rapamycin-mediated rictor dephosphorylation is time and concentration dependent, and occurs at physiologically relevant rapamycin concentrations. siRNA knockdown of mTOR also leads to rictor dephosphorylation, suggesting that rictor phosphorylation is mediated by mTOR or one of its downstream targets. Rictor phosphorylation induced by serum, insulin and insulin-like growth factor is blocked by rapamycin. Rictor dephosphorylation is not associated with dephosphorylation of Akt Ser473. Further work is needed to better characterize the mechanism of rictor regulation and its role in rapamycin-mediated growth inhibition.
authors: Department of Surgical Oncology, The University of Texas MD, Anderson Cancer Center, Houston, TX 77030, USA.
authors: Argun
authors: A
authors: Akcakanat
authors: Gopal
authors: G
authors: Singh
authors: Mien-Chie
authors: MC
authors: Hung
authors: Funda
authors: F
authors: Meric-Bernstam
mesh_terms: D015153:Blotting, Western; D002352:Carrier Proteins / Q000378:metabolism*; D045744:Cell Line, Tumor; D004591:Electrophoresis, Polyacrylamide Gel; D006801:Humans; D010766:Phosphorylation / Q000187:drug effects; D011494:Protein Kinases / Q000235:genetics / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D034741:RNA, Small Interfering / Q000235:genetics; D000076226:Rapamycin-Insensitive Companion of mTOR Protein; D020123:Sirolimus / Q000494:pharmacology*; D058570:TOR Serine-Threonine Kinases; D014162:Transfection
chemical_list: D002352:Carrier Proteins; C492571:RICTOR protein, human; D034741:RNA, Small Interfering; D000076226:Rapamycin-Insensitive Companion of mTOR Protein; D011494:Protein Kinases; C546842:MTOR protein, human; D051057:Proto-Oncogene Proteins c-akt; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus
references: Cell. 2002 Jul 26;110(2):163-75
references: 12150925
references: Clin Cancer Res. 2004 Feb 1;10(3):1013-23
references: 14871980
references: Curr Biol. 2004 Jul 27;14(14):1296-302
references: 15268862
references: Clin Cancer Res. 2004 Oct 15;10(20):7031-42
references: 15501983
references: Nat Cell Biol. 2004 Nov;6(11):1122-8
references: 15467718
references: Cancer Res. 2005 Mar 1;65(5):1961-72
references: 15753396
references: Mol Cancer Ther. 2005 Oct;4(10):1533-40
references: 16227402
references: J Biol Chem. 2005 Dec 9;280(49):40406-16
references: 16221682
references: Cancer Res. 2006 Feb 1;66(3):1500-8
references: 16452206
references: Mol Cell. 2006 Apr 21;22(2):159-68
references: 16603397
references: Cancer Cell. 2006 Aug;10(2):89-91
references: 16904605
references: Cancer Cell. 2006 Aug;10(2):159-70
references: 16904613
references: Genes Dev. 2006 Oct 15;20(20):2820-32
references: 17043309
references: Blood. 2007 Apr 15;109(8):3509-12
references: 17179228
references: Biochem J. 2007 Aug 1;405(3):513-22
references: 17461779
references: J Biol Chem. 2007 Aug 31;282(35):25604-12
references: 17599906